BioTuesdays

Giving healthcare companies and their stories the exposure they deserve.

Subscribe

THIS WEEK'S FEATURE

MORE FEATURES

Spring Bank heading into data-rich 2020

Spring Bank Pharmaceuticals (NASDAQ:SBPH) will be reporting clinical data readouts throughout 2020 as it advances a portfolio of three drug candidates for the treatment of chronic hepatitis B virus (HBV) as well as...


NEWS

WB ups Diplomat Pharmacy to market perform

William Blair upgraded Diplomat Pharmacy (NYSE:DPLO) to “market perform” from “underperform” after UnitedHealth Group’s (NYSE:UNH) OptumRx agreed to acquire Diplomat for $4 a share. Shares of Diplomat were quoted at $3...


Just a few of the companies we’ve highlighted along the way

coverage

Subscribe

Sign up to our weekly BioTuesdays newsletter.